These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25528857)

  • 1. [Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].
    Zviagintseva TD; Hlushchenko SV
    Lik Sprava; 2014 Nov; (11):154-5. PubMed ID: 25528857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.
    Patel V; Sanyal AJ; Sterling R
    Clin Liver Dis; 2016 May; 20(2):277-92. PubMed ID: 27063269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of nonalcoholic steatohepatitis: Emerging approaches.
    Pan Q; Fan JG
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):1-3. PubMed ID: 30611667
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.
    Angulo P; Machado MV; Diehl AM
    Semin Liver Dis; 2015 May; 35(2):132-45. PubMed ID: 25974899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Arvind A; Osganian SA; Sjoquist JA; Corey KE; Simon TG
    Gastroenterology; 2020 Dec; 159(6):2232-2234.e4. PubMed ID: 32768596
    [No Abstract]   [Full Text] [Related]  

  • 8.  Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease.
    Minuk GY; Sanders J; O'Brien M; Uhanova J
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):944-945. PubMed ID: 27740531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease].
    Kurbatova IV; Dudanova OP
    Ter Arkh; 2017; 89(2):52-58. PubMed ID: 28281516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
    Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
    Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression: Divergent paths.
    DeWeerdt S
    Nature; 2017 Nov; 551(7681):. PubMed ID: 29168825
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis.
    Hendrikx T; Walenbergh SM; Jeurissen ML; Houben T; van Gorp PJ; Lindsey PJ; Koek GH; Kalhan S; Pihlajamaki J; Hofker MH; Shiri-Sverdlov R
    Biomark Med; 2015; 9(12):1301-9. PubMed ID: 26612588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
    Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
    Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of silent myocardial ischiemia with the course of rheumatoid arthritis and hyperhomocysteinemia].
    Galiutina OIu; Bychak OV
    Lik Sprava; 2011; (1-2):48-52. PubMed ID: 21954634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease.
    Alisi A; Nobili V; Ceccarelli S; Panera N; De Stefanis C; De Vito R; Vitali R; Bedogni G; Balsano C; Cucchiara S; Stronati L
    Expert Rev Mol Diagn; 2014 Jul; 14(6):763-71. PubMed ID: 24927058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining.
    Yoshimura K; Okanoue T; Ebise H; Iwasaki T; Mizuno M; Shima T; Ichihara J; Yamazaki K
    Hepatology; 2016 Feb; 63(2):462-73. PubMed ID: 26390046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.